BUSINESS● LOWSep 8 · Sep 8, 2026, 9:38 AM
Switzerland's Sandoz aims to double sales by 2035 in expanded biosimilars push
Seeking Alpha Tech · western europe
Switzerland's Sandoz aims to double its sales by 2035, driven by an expanded push into biosimilars. This indicates the company's long-term growth strategy within the pharmaceutical market.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS23m agoHong Kong’s art trading hub ambitions rest on more than headline salesSouth China Morning PostBUSINESS53m agoPump pressure: how rising fuel costs leave Hong Kong drivers running on fumesSouth China Morning Post